Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol

Journal of the American Academy of Dermatology

Volumn 59, Issue 4, 2008, Pages 589-595

  Arulogun, Suzanne ^a   Prince, H Miles ^a,c   Gambell, Peter ^a   Lade, Stephen ^a   Ryan, Gail ^a,c   Eaton, Eve ^a   McCormack, Christopher ^b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; DENILEUKIN DIFTITOX; METHOTREXATE; METHOXSALEN; PANOBINOSTAT; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PUVA; RETROSPECTIVE STUDY; SAMPLE SIZE; SEZARY SYNDROME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; METHOTREXATE; MIDDLE AGED; PHOTOPHERESIS; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN NEOPLASMS; SURVIVAL RATE; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME;

EID: 51349148324     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.05.038     Document Type: Article

References (26)

1. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
2. Willemze R., Kerl H., Sterry W., Berti E., Cerroni L., Chimenti S., et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 90 (1997) 354-371
3. Lamberg S.I., and Bunn Jr. P.A. Cutaneous T-cell lymphomas: summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute workshop. Arch Dermatol 115 (1979) 1103-1105
4. Olsen E., Vonderheid E., Pimpinelli N., Willemze R., Kim Y., Knobler R., et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 (2007) 1713-1722
5. Whittaker S.J., Marsden J.R., Spittle M., and Russell Jones R. Joint British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 149 (2003) 1095-1107
6. Foss F.M. New insights into the mechanism of action of extracorporeal phototherapy. Transfusion (Paris) 46 (2006) 6-8
7. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 316 (1987) 297-303
8. Heald P.W., Perez M.I., Christensen I., Dobbs N., McKiernan G., and Edelson R. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience. Yale J Biol Med 62 (1989) 629-638
9. Armus S., Keyes B., Cahill C., Berger C., Crater D., Scarborough D., et al. Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 23 (1990) 898-902
10. Prinz B., Behrens W., Holzle E., and Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma-the Dusseldorf and Munich experience. Arch Dermatol Res 287 (1995) 621-626
11. Zic J.A., Stricklin G.P., Greer J.P., Kinney M.C., Shyr Y., Wilson D.C., et al. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 35 (1996) 935-945
12. Gottlieb S.L., Wolfe J.T., Fox F.E., DeNardo B.J., Macey W.H., Bromley P.G., et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol 35 (1996) 946-957
13. Duvic M., Hester J.P., and Lemak N.A. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 35 (1996) 573-579
14. Gollnick H.P., Owsianowski M., Ramaker J., Chun S.C., and Orfanos C.E. Extracorporeal photopheresis-a new approach for the treatment of cutaneous T cell lymphomas. Recent Results Cancer Res 139 (1995) 409-415
15. Russell-Jones R., Fraser-Andrews E.A., Spittle M., and Whittaker S. Extracorporeal photopheresis in Sézary syndrome. Lancet 350 (1997) 886
16. Konstantinow A., and Balda B.R. Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Eur Acad Dermatol Venereol 9 (1997) 111-117
17. Dippel E., Schrag H., Goerdt S., and Orfanos C. Extracorporeal photopheresis and interferon-[alpha] in advanced cutaneous T-cell lymphoma. Lancet 350 (1997) 32-33
18. Vonderheid E.C., Zhang Q., Lessin S.R., Polansky M., Abrams J.T., Bigler R.D., et al. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 38 (1998) 207-220
19. Bisaccia E., Gonzalez J., Palangio M., Schwartz J., and Klainer A.S. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. J Am Acad Dermatol 43 (2000) 263-271
20. Wollina U., Liebold K., Kaatz M., Looks A., Stuhlert A., and Lange D. Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy. Oncol Rep 7 (2000) 1197-1201
21. Evans A.V., Wood B.P., Scarisbrick J.J., Fraser-Andrews E.A., Chinn S., Dean A., et al. Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictors of response. Blood 98 (2001) 1298-1301
22. Russell-Jones R. Extracorporeal photopheresis in cutaneous T-cell lymphoma: inconsistent data underline the need for randomized studies. Br J Dermatol 142 (2000) 16-21
23. Zic J.A., Miller J.L., Stricklin G.P., and King Jr. L.E. The North American experience with photopheresis. Ther Apher Dial 3 (1999) 50-62
24. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457
25. Bernengo M.G., Quaglino P., Novelli M., Cappello N., Doveil G.C., Lisa F., et al. Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, hematological and immunological features. Ann Oncol 9 (1998) 857-863
26. - lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sezary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis. Arch Dermatol 138 (2002) 1347-1350